If you want to understand the spread of antibiotic resistance across Europe, sexually transmitted diseases seem to be a decent barometer.
Gonorrhea,
caused by the bacterium Neisseria gonorrhoeae, is the second most prevalent bacterial sexually transmitted disease globally. The WHO estimates that Gonorrhea infects 88 million people globally each year. Amongst other complications, it can cause pelvic inflammatory disease and infertility if left untreated, and in some cases leads to life-threatening complications such as meningitis. Transmitted during unprotected sex, many strains of Gonorrhea are now difficult to treat due to the rise in antibiotic resistance.
A new study using a massive database of scientific articles, 486,644 articles with two to nine authors published in medical journals by U.S. scientists between 1946 and 2009, suggests that minority women are not double penalized by being minorities and women, but they do have what might be called a "one-and-a-half bind." They are still worse off than other groups, but their disadvantage is less than the disadvantage of being black or Hispanic plus the disadvantage of being a woman.
There are obvious confounders. Medical journals are a small subset of journals and journals will have more academic representation, since that is the metric government panels use to give out grants, a concern private sector scientists don't have.
A.I. - artificial intelligence - has seen a resurgence of buzzword activity. It's the Internet of Things for 2018. But if the limitation is the algorithm underneath, it's not really AI.
Francisella tularensis bacteria are the cause of tularemia, a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. The bacteria are able to suppress host inflammation when infecting mouse and human cells - and lipids help. A lipid is waxy, fatty acid but what helps bacterium to impair the host immune response and increase the chance of infection may also be a potent inflammation therapy against bacterial and viral diseases.
The P120C solid-fuel rocket motor that will power Ariane 6 and Vega-C at liftoff has been transferred to the test stand for its first hot firing at Europe’s Spaceport.
P120C will replace P80 as the first stage motor of Vega-C, which is expected to debut in mid-2019 and comprises four stages. Three stages will use solid-propellant motors and one will use liquid propellants. The first stage is the P120C, the largest monolithic carbon fiber solid-propellant rocket motor ever built. Two or four P120Cs will also be strapped onto Ariane 6 as boosters for liftoff.